Rozerem.biz

Rozerem will have you Saying Goodbye to Sleepless Nights

Patient controlled studies and numerous clinical trials have demonstrated that an increasing number of people have trouble sleeping. They suffer from chronic insomnia due to an active yet stressful lifestyle, excessive working and unhealthy eating. Rozerem is a newly introduced drug, a potent sleeping agent intended to be used on a long-term basis. The medication works by binding in a selective manner with melatonin receptors, unlike other sleeping medication, with influence on GABA A receptors.

Rozerem is the name under which Ramelteon has been marketed, approved for long-term usage by the Federal Drug Administration (FDA). The medication is preferred for the treatment of insomnia versus other drugs existent on the market, due to lack of upsetting side-effects. Rozerem does not present a risk for blackouts or tendency to forget, commonly encountered in situations where GABA A receptors are involved. The major indication of Rozerem is represented by insomnia, particularly in patients who have a difficult time falling asleep, the onset of the initial sleep phase being delayed to an excessive degree.

As there are many sleeping agents producing dependence, studies for Rozerem concentrated on this particular aspect as well. It was found that the medication is completely safe, presenting absolutely no risk for either physical or mental dependence. At the same time, the potential for substance abuse does not exist. The advantage of using Rozerem also comes from the fact that long-term administration will not lead to severe withdrawal symptoms in case of sudden termination. As opposed to other sleeping agents, Rozerem has a different action mechanism and is highly unlikely to produce rebound insomnia after the treatment is finished.

The Internet presents detailed information about Rozerem, with the results of different studies and patient trials. After reading all this information, you will discover that Rozerem is a prescription drug approved by the FDA for the treatment of insomnia. Medical specialists recommended Rozerem to be taken by those who have delayed sleep phases. Once it enters the human body, the medication has a bioavailability of 1.8% and an incredibly capacity of binding to plasmatic proteins, of 82%. The drug is metabolized mainly in the liver, having a half-life that varies somewhere between 1 and 2 1/2 hours. Rozerem is excreted in the kidneys up to a large percent (84%) but also through the feces in a smaller proportion. The main administration route is oral.

The mechanism of action for Rozerem has been carefully studies by various universities and medical research teams. It was found that Rozerem is a powerful melatonin receptor agonist. The drug presents a high affinity of melatonin receptors, having the property of being selective. Rozerem promotes sleep by interacting with melatonin receptors, helping to the normal process of sleeping, with the circadian rhythm respected. By taking Rozerem, you can be certain that insomnia will be a thing of the past. The doctor will explain to you how this medication works but also provide additional information about normal sleep-wake patterns and melatonin receptors.

It was mentioned that Rozerem does not bind with GABA receptors and thus presents low risks for undesired side-effects. Studies have clearly demonstrated that Rozerem has absolutely no affinity for these receptors and neither for the following: serotonin, dopamine, norepinephrin or opiate receptors. Rozerem has one major active metabolite, which surprisingly is not as powerful as the parent drug. The affinity potential is also lower but MII compensates by entering the blood stream and circulating in higher concentrations. Thus, it helps to a better distribution of the medication, promoting efficient sleep.

Are there any drugs interacting with Rozerem? The medication has been carefully analyzed with the help of patient-controlled studies. Different drugs were co-administered at the same time with Rozerem, specialists being ready to notice the appearance of side-effects and their severity. The results of the tests showed that Rozerem does not interact with antacids (such as omeprazole, destined to reduce the secretion of the acid in the stomach), bronchial dilators (theophylline) or benzodiazepines (sedatives). Digoxin and warfarin are two other drugs which are safe to be used when the patient is under treatment with Rozerem. Caution should be taken in case of antifungal medication and it seems that an absolute contraindication is represented by SSRIs (selective serotonin reuptake inhibitors) antidepressants. The efficacy of Rozerem is also reduced when antibacterial drugs are administered concomitantly.

Generally, Rozerem is approved for adults who suffer from insomnia. The medication is not be taken by those who have been diagnosed with liver disease or renal failure. Rozerem must never be associated with high alcohol consumption. The best thing for you to do is consult your doctor and discuss about all the aspects that were mentioned. You might also want to inquire about the risk of Rozerem affecting your sexual desire. If the medication does not resolve your problems with insomnia, contact your doctor and ask about a possible dosage modification. Take the medication before you go to bed and prepare yourself for the possible side-effects that are likely to appear, including somnolence, fatigue and vertigo.